5-fluoro-1,2,3,4,5,6,6a,10b-octahydro-2,5-methanodicyclopenta[a,b]inden-2-amine

ID: ALA5187677

Chembl Id: CHEMBL5187677

PubChem CID: 168279330

Max Phase: Preclinical

Molecular Formula: C16H18FN

Molecular Weight: 243.32

Associated Items:

Names and Identifiers

Canonical SMILES:  NC12CC3c4ccccc4C4CC(F)(C1)CC34C2

Standard InChI:  InChI=1S/C16H18FN/c17-14-5-12-10-3-1-2-4-11(10)13-6-15(18,7-14)9-16(12,13)8-14/h1-4,12-13H,5-9,18H2

Standard InChI Key:  IXSYMZJDFHHWMM-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5187677

    ---

Associated Targets(Human)

CYP1A2 Tchem Cytochrome P450 1A2 (26471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C19 Tchem Cytochrome P450 2C19 (29246 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C9 Tchem Cytochrome P450 2C9 (32119 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2D6 Tclin Cytochrome P450 2D6 (33882 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP3A4 Tclin Cytochrome P450 3A4 (53859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Grin1 Glutamate NMDA receptor; Grin1/Grin2a (798 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
N2a (708 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Caenorhabditis elegans (1055 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 243.32Molecular Weight (Monoisotopic): 243.1423AlogP: 3.25#Rotatable Bonds:
Polar Surface Area: 26.02Molecular Species: BASEHBA: 1HBD: 1
#RO5 Violations: HBA (Lipinski): 1HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 10.46CX LogP: 1.85CX LogD: -0.89
Aromatic Rings: 1Heavy Atoms: 18QED Weighted: 0.74Np Likeness Score: 0.53

References

1. Turcu AL, Companys-Alemany J, Phillips MB, Patel DS, Griñán-Ferré C, Loza MI, Brea JM, Pérez B, Soto D, Sureda FX, Kurnikova MG, Johnson JW, Pallàs M, Vázquez S..  (2022)  Design, synthesis, and in vitro and in vivo characterization of new memantine analogs for Alzheimer's disease.,  236  [PMID:35453065] [10.1016/j.ejmech.2022.114354]

Source